pnb-0408 dihexa clinical trial (also known as PNB-0408) is an experimental small molecule derived from angiotensin IV. It was engineered to cross the blood–brain barrier and has shown synaptogenic effects in preclinical models. The often-quoted what does dihexa peptide do
Description
So excited

This article covers what's new for 2026 and why testing depth matters more than ever

While STING can induce autophagy, autophagy can degrade STING through multiple mechanisms including microautophagy and selective macroautophagy

Cells are separated from the interstitial fluid by a selectively permeable cell membrane that helps regulate the passage of materials between the interstitial fluid and the interior of the cell
